Gut bacterial metabolite imidazole propionate potentiates Alzheimer's disease pathology
Vemuganti, V.; Kang, J. W.; Zhang, Q.; Martinez, R. A.; Harpt, J. L.; Harding, S. J.; Deming, Y.; Johnson, S. C.; Asthana, S.; Zetterberg, H.; Blennow, K.; Engelman, C.; Ulland, T. K.; Bäckhed, F.; Bendlin, B. B.; Rey, F. E.
Show abstract
The gut microbiome modulates metabolic, immune, and neurological functions and has been implicated in Alzheimers disease (AD), though the specific mechanisms remain poorly defined. The bacterial metabolite imidazole propionate (ImP) has been previously associated with several AD comorbidities, such as type 2 diabetes and cardiovascular disease. Here, we show that elevated plasma ImP levels are associated with lower cognitive scores and AD biomarkers in a cohort of >1,100 cognitively unimpaired individuals. Metagenomic profiling identified gut bacteria encoding putative orthologs of the ImP-synthesizing enzyme, urocanate reductase (UrdA), whose abundance correlated with both cognitive measures and multiple AD biomarkers. Chronic ImP administration to mice activated neurodegenerative pathways, worsened AD-like neuropathology, and increased blood-brain barrier (BBB) permeability. Complementary in vitro studies showed that ImP compromised the integrity of human brain endothelial cells. Collectively, these findings implicate ImP in AD progression via both neurodegenerative and cerebrovascular mechanisms, identifying it as a potential target for early intervention. One Sentence SummaryGut bacterial metabolite increases dementia risk.
Matching journals
The top 9 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Low circulating choline, a modifiable dietary factor, is associated with the pathological progression and metabolome dysfunction in Alzheimers disease. 96%
- Rare genetic variation in Fibronectin 1 (FN1) protects against APOEe4 in Alzheimer's disease 96%
- Genome-wide association study and functional validation implicates JADE1 in tauopathy 96%
Similar papers in this journal
- Aβ oligomers trigger necroptosis-mediated neurodegeneration via microglia activation in Alzheimer's disease. 97%
- C5aR1 antagonism alters microglial polarization and mitigates disease progression in a mouse model of Alzheimers disease 96%
- Retinal ganglion cell vulnerability to pathogenic tau in Alzheimer's disease 96%
Similar papers in this journal
- Interrogating the plasma proteome of repetitive head impact exposure and chronic traumatic encephalopathy 97%
- APOE Christchurch enhances a disease-associated microglial response to plaque but suppresses response to tau pathology 97%
- Cerebrospinal fluid total tau levels indicate aberrant neuronal plasticity in Alzheimer’s disease 97%
Similar papers in this journal
- Identification of Chlamydia pneumoniae and NLRP3 inflammasome activation in Alzheimer's disease retina 96%
- Plasma p-tau212: antemortem diagnostic performance and prediction of autopsy verification of Alzheimer’s disease neuropathology 95%
- A public resource of single cell transcriptomes and multiscale networks from persons with and without Alzheimer's disease 95%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.